Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient dataPaul A. Cohen, Arjun Jeyarajah, Max Bulsara et al.|Gynecologic Oncology|2019Cited by 121
Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST StudyDhivya Chandrasekaran, Ranjit Manchanda, Monika Sobočan et al.|Cancers|2021Cited by 49
A phase I trial of the oral hedgehog inhibitor taladegib (LY2940680) in combination with weekly paclitaxel in patients with advanced, solid tumours.Rosalind Glasspool, T.R. Jeffry Evans, Sarah P. Blagden et al.|Journal of Clinical Oncology|2017Cited by 3